INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Quarterly Results

Change Company Name

Laurus Labs Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 540222	ISIN Demat INE947Q01028	Book Value 84.55	NSE Symbol LAURUSLABS	Dividend Yield (%) 0.14	Market Cap (₹ Cr.) 45,779.85	P/E 89.84	EPS 9.44	Face Value 2

Particulars (₹ Cr)	Jun 2025	Mar 2025	Dec 2024	Sep 2024

Gross Sales/Income from operations	1432.75	1650.01	1265.19	1184.85
Less: Excise duty	0.00	0.00	0.00	0.00
Net Sales/Income from operations	1,432.75	1,650.01	1,265.19	1,184.85
Other Operating Income	0.00	0.00	0.00	0.00
Total Income from operations (net)	1,432.75	1,650.01	1,265.19	1,184.85
Total Expenses	1,198.94	1,343.37	1,147.57	1,093.96
Cost of Sales	610.21	781.45	600.94	560.84
Employee Cost	179.90	148.77	161.70	148.94
Depreciation, amortization and depletion expense	93.57	88.19	88.66	90.94
Provisions & Write Offs	0.00	0.00	0.00	0.00
Administrative and Selling Expenses	0.00	0.00	0.00	0.00
Other Expenses	315.26	324.96	296.27	293.24
Pre Operation Expenses Capitalised	0.00	0.00	0.00	0.00
Profit from operations before other income, finance costs and exceptional items	233.81	306.64	117.62	90.89
Other Income	21.52	72.16	7.12	11.89
Profit from ordinary activities before finance costs and exceptional items	255.33	378.80	124.74	102.78
Finance Costs	43.89	48.60	48.02	44.69
Profit from ordinary activities after finance costs but before exceptional items	211.44	330.20	76.72	58.09
Exceptional Items	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00
Profit from ordinary activities before tax	211.44	330.20	76.72	58.09
Total Tax	53.50	78.30	19.45	15.65
Net profit from Ordinary Activities After Tax	157.94	251.90	57.27	42.44
Profit / (Loss) from Discontinued Operations	0.00	0.00	0.00	0.00
Net profit from Ordinary Activities/Discontinued Operations After Tax	157.94	251.90	57.27	42.44
Extraordinary items	0.00	0.00	0.00	0.00
Other Adjustments After Tax	0.00	0.00	0.00	0.00
Net Profit after tax for the Period	157.94	251.90	57.27	42.44
Other Comprehensive Income	-0.19	-1.61	0.28	0.29
Total Comprehensive Income	157.75	250.29	57.55	42.73
Equity	107.96	107.85	107.85	107.83
Reserve & Surplus	0.00	0.00	0.00	0.00
Face Value	2.00	2.00	2.00	2.00
EPS:
EPS before Exceptional/Extraordinary items-Basic	2.93	4.68	1.06	0.79
EPS before Exceptional/Extraordinary items-Diluted	2.93	4.67	1.06	0.79
EPS after Exceptional/Extraordinary items-Basic	2.93	4.68	1.06	0.79
EPS after Exceptional/Extraordinary items-Diluted	2.93	4.67	1.06	0.79
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00
Dividend Per Share(Rs.)	0.00	0.00	0.00	0.40
Dividend (%)	0.00	0.00	0.00	20.00
No. of Employees	0.00	0.00	0.00	0.00
Debt Equity Ratio	0.00	0.00	0.00	0.00
Debt Service Coverage Ratio	0.00	0.00	0.00	0.00
Interest Service Coverage Ratio	0.00	0.00	0.00	0.00
Debenture Redemption Reserve (Rs cr)	0.00	0.00	0.00	0.00
Paid up Debt Capital (Rs cr)	0.00	0.00	0.00	0.00